• FDA approves first cannabis-based drug to treat epilepsy pharmaceutical-technology
    June 28, 2018
    UK-based GW Pharmaceuticals has secured approval from the US Food and Drug Administration (FDA) for its marijuana-based Epidiolex oral solution to treat seizures caused due to Lennox-Gastaut syndrome and Dravet syndrome
PharmaSources Customer Service